Attached files

file filename
10-Q - QUARTERLY REPORT - Advanced Biomedical Technologies Inc.abmt_10q.htm
EX-32.2 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex322.htm
EX-31.2 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex312.htm
EX-32.1 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex321.htm
EX-31.1 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex311.htm
v3.2.0.727
Label Element Value
Depreciation us-gaap_Depreciation $ 6,606
Depreciation us-gaap_Depreciation 8,018
NET LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (210,712)
NET LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (211,530)